Hana Pharm announced on the 18th that it had signed a sub-license contract with Hyphens Pharma of Singapore for the exclusive rights to Byfavo 20mg, an anesthetic new drug. This contract is the first achievement of local partnering while Hana Pharm received licenses for six Southeast Asian countries from German PiON in 2020 and was in the process of obtaining licenses for each country.

Byfavo 20mg has indications for surgical sedation that can be used for endoscopic sedation in addition to induction and maintenance of general anesthesia, which is the indication for 50mg. Hyphens Pharma of Singapore is a major pharmaceutical company in Singapore with branches in five major Southeast Asian countries and a